×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Ocuphire Pharma Inc. (OCUP) NASDAQ

$2.01 (0.01) (-0.50%)

Market Cap: $49.87M

As of 03/28/24 04:00 PM EDT. Market closed.

(OCUP)

Ocuphire Pharma Inc. (OCUP)
NASDAQ

$2.01
(0.01) (-0.50%)

Market Cap: $49.87M

As of 03/28/24 04:00 PM EDT. Market closed.

Add to Portfolio

ocuphire is a new biopharmaceuticals company focused on developing and commercializing small molecule drugs for unmet medical needs in the ocular disease space. ocuphire’s lead drug candidate, nyxol eye drops, is aimed to treat patients with night vision disturbances (nvd), glaucoma and presbyopia (impaired near-term vision). ocuphire is in discussions with a prospective late stage ophthalmic ... read more

ocuphire is a new biopharmaceuticals company focused on developing and commercializing small molecule drugs for unmet medical needs in the ocular disease space. ocuphire’s lead drug candidate, nyxol eye drops, is aimed to treat patients with night vision disturbances (nvd), glaucoma and presbyopia (impaired near-term vision). ocuphire is in discussions with a prospective late stage ophthalmic drug program that could be developed in parallel. ocuphire's management team has over 100 years of drug development expertise across a diverse set of therapeutic areas including ophthalmology, orphan, cardio-metabolic, nephrology, oncology and respiratory. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
15245 Shady Grove Rd Ste 455, Maryland, Rockville, 20850-7203.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Douglas Swirsky
Address
15245 Shady Grove Rd Ste 455, Maryland, Rockville, 20850-7203.
PRICE CHART FOR OCUPHIRE PHARMA INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$2
Previous Close
$2.02
Days Range
$1.99 - $2.03
52 week range
$1.85 - $6.60
Volume
124,374
Avg. Volume (30 days)
224,654
Market Cap
$49.87M
Dividend Yield
-
P/E
-
Shares Outstanding
24,813,370
Open
$2
Previous Close
$2.02
Days Range
$1.99 - $2.03
52 week range
$1.85 - $6.60
Volume
124,374
Avg. Volume (30 days)
224,654
Market Cap
$49.87M
Dividend Yield
-
P/E
-
Shares Outstanding
24,813,370
FINANCIAL STATEMENTS FOR OCUPHIRE PHARMA INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR OCUPHIRE PHARMA INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
SCHACHLE JOSEPH KChief Operating OfficerMar 21, 2024 Buy$2.052,0004,1002,000Mar 25, 2024, 04:44 PM
Jhaveri Nirav S.Chief Financial OfficerMar 21, 2024 Buy$2.1010,00021,000150,000Mar 25, 2024, 04:40 PM
Magrath GeorgeChief Executive OfficerMar 18, 2024 Buy$1.9625,00049,050425,000Mar 20, 2024, 04:18 PM
Zaremba Rabourn AmySVP of FinanceJan 10, 2024 Option Exercise$3.273,95012,89742,658Jan 12, 2024, 04:17 PM
Patel Ronil A.Chief Business OfficerJan 10, 2024 Option Exercise$3.271,2824,18690,714Jan 12, 2024, 04:17 PM
Hoffmann BernhardSVP of Corp. Dev.Jan 10, 2024 Option Exercise$3.274,03113,161142,697Jan 12, 2024, 04:17 PM
Gallagher CamDirectorJan 04, 2023 Option Exercise$0.001,574024,928Jan 06, 2023, 09:00 AM
Ainsworth SeanDirectorOct 19, 2022 Option Exercise$0.001,574041,239Oct 20, 2022, 04:01 PM
MANUSO JAMES S JDirectorOct 11, 2022 Option Exercise$0.00787036,465Oct 12, 2022, 04:23 PM
Rodgers Richard JDirectorOct 03, 2022 Option Exercise$0.003,148067,424Oct 04, 2022, 09:00 AM
Sooch MinaPresident and CEOSep 06, 2022 Option Exercise$0.001,0230426,045Sep 08, 2022, 04:01 PM
MANUSO JAMES S JDirectorMay 20, 2022 Buy$1.995,0009,95021,570May 24, 2022, 09:43 AM
Sooch MinaPresident and CEOMay 20, 2022 Buy$2.0212,50025,300425,022May 23, 2022, 04:58 PM
Sooch MinaPresident and CEOMay 19, 2022 Buy$2.0712,50025,879412,522May 23, 2022, 04:58 PM
Pepose JayDirectorDec 13, 2021 Buy$3.658,25030,11322,994Dec 14, 2021, 08:44 PM
MANUSO JAMES S JDirectorNov 18, 2021 Buy$3.502,0007,00016,570Nov 22, 2021, 04:01 PM
Pepose JayDirectorSep 13, 2021 Buy$4.7512,63159,99714,744Sep 15, 2021, 08:00 AM
Benton SusanDirectorSep 02, 2021 Buy$4.5720,00091,40023,976Sep 03, 2021, 04:02 PM
Beever CharlesDirectorJan 31, 2019 Buy$0.6410,0006,38011,000Feb 04, 2019, 04:53 PM
Price Ben GilDirectorJan 29, 2019 Buy$0.6115,0009,14115,000Jan 31, 2019, 07:56 AM
Nolan LisaChief Business OfficerJan 30, 2019 Buy$0.6520,00012,96021,625Jan 31, 2019, 07:48 AM
Swirsky Douglas JPresident and CEOJan 29, 2019 Buy$0.6350,00031,72050,000Jan 30, 2019, 07:32 AM
Suzdak Peter DavidChief Executive OfficerAug 16, 2017 Option Exercise$1.9910,00019,87216,000Aug 16, 2017, 04:05 PM
Ahn Chang HoDirectorApr 10, 2017 Option Exercise$0.31250,00077,5006,260,000Apr 12, 2017, 05:26 PM
Ahn Chang HoDirectorApr 10, 2017 Sale$0.70250,000175,3756,010,000Apr 12, 2017, 05:26 PM
Suzdak Peter DavidChief Executive OfficerMar 18, 2016 Option Exercise$0.3260,00019,38660,000Mar 21, 2016, 09:20 PM
Jeong Tae HeumChief Financial OfficerJan 08, 2015 Option Exercise$0.8078,78263,026583,782Jan 12, 2015, 06:22 PM
Jeong Tae HeumChief Financial OfficerJan 12, 2015 Option Exercise$0.8049,80039,840554,800Jan 12, 2015, 06:22 PM
Jeong Tae HeumChief Financial OfficerJan 09, 2015 Option Exercise$0.80188,690150,952693,690Jan 12, 2015, 06:22 PM
Jeong Tae HeumChief Financial OfficerJan 08, 2015 Sale$0.9078,78270,935505,000Jan 12, 2015, 06:22 PM
Jeong Tae HeumChief Financial OfficerJan 12, 2015 Sale$0.9149,80045,492505,000Jan 12, 2015, 06:22 PM
Jeong Tae HeumChief Financial OfficerJan 09, 2015 Sale$0.92188,690172,708505,000Jan 12, 2015, 06:22 PM
Ahn Chang HoDirectorJan 08, 2015 Option Exercise$0.8080,00064,0006,090,000Jan 12, 2015, 06:11 PM
Ahn Chang HoDirectorJan 12, 2015 Option Exercise$0.8048,44438,7556,058,444Jan 12, 2015, 06:11 PM
Ahn Chang HoDirectorJan 09, 2015 Option Exercise$0.80186,212148,9706,196,212Jan 12, 2015, 06:11 PM
Ahn Chang HoDirectorJan 08, 2015 Sale$0.9080,00072,0326,010,000Jan 12, 2015, 06:11 PM
Ahn Chang HoDirectorJan 12, 2015 Sale$0.9148,44444,2636,010,000Jan 12, 2015, 06:11 PM
Ahn Chang HoDirectorJan 09, 2015 Sale$0.92186,212170,4776,010,000Jan 12, 2015, 06:11 PM
Ahn Chang HoDirectorJun 12, 2014 Option Exercise$0.80136,193108,9546,950,117Jun 16, 2014, 07:48 PM
Ahn Chang HoDirectorJun 12, 2014 Sale$0.99136,193134,4366,813,924Jun 16, 2014, 07:48 PM
McIntosh David MDirectorApr 14, 2014 Option Exercise$1.0199,010100,00025,990Apr 16, 2014, 04:18 PM
McIntosh David MDirectorApr 14, 2014 Option Exercise$0.80125,000100,000125,000Apr 16, 2014, 04:18 PM
Jeong Tae HeumChief Financial OfficerSep 09, 2013 Option Exercise$0.4678,86136,000576,139Sep 11, 2013, 06:01 PM
Jeong Tae HeumChief Financial OfficerSep 09, 2013 Option Exercise$0.24150,00036,000655,000Sep 11, 2013, 06:01 PM
Jeong Tae HeumChief Financial OfficerSep 09, 2013 Sale$0.4671,13932,475505,000Sep 11, 2013, 06:01 PM
Kivel RichardDirectorOct 03, 2011 Buy$1.042,5002,6002,500Oct 21, 2011, 04:41 PM
Brandt Peter C.DirectorSep 09, 2011 Buy$1.2280,00097,571150,000Sep 12, 2011, 04:38 PM
Brandt Peter C.DirectorSep 08, 2011 Buy$1.1045,00049,28470,000Sep 12, 2011, 04:38 PM
Brandt Peter C.DirectorSep 06, 2011 Buy$0.9520,00018,92320,000Sep 08, 2011, 05:54 PM
Brandt Peter C.DirectorSep 07, 2011 Buy$1.045,0005,20025,000Sep 08, 2011, 05:54 PM
Ahn Chang HoChairman & CEOMay 18, 2011 Buy$1.311,008,0781,320,58211,338,924May 20, 2011, 04:30 PM
Ahn Chang HoChairman & CEOApr 01, 2011 Buy$1.22320,846391,43210,330,846Apr 05, 2011, 05:00 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
SCHACHLE JOSEPH KChief Operating Officer03/21/20244,100
Jhaveri Nirav S.Chief Financial Officer03/21/202421,000
Magrath GeorgeChief Executive Officer03/18/202449,050
Zaremba Rabourn AmySVP of Finance01/10/202412,897
Patel Ronil A.Chief Business Officer01/10/20244,186
Hoffmann BernhardSVP of Corp. Dev.01/10/202413,161
Gallagher CamDirector01/04/20230
Ainsworth SeanDirector10/19/20220
MANUSO JAMES S JDirector10/11/20220
Rodgers Richard JDirector10/03/20220
Sooch MinaPresident and CEO09/06/20220
MANUSO JAMES S JDirector05/20/20229,950
Sooch MinaPresident and CEO05/20/202225,300
Sooch MinaPresident and CEO05/19/202225,879
Pepose JayDirector12/13/202130,113
MANUSO JAMES S JDirector11/18/20217,000
Pepose JayDirector09/13/202159,997
Benton SusanDirector09/02/202191,400
Beever CharlesDirector01/31/20196,380
Price Ben GilDirector01/29/20199,141
Nolan LisaChief Business Officer01/30/201912,960
Swirsky Douglas JPresident and CEO01/29/201931,720
Suzdak Peter DavidChief Executive Officer08/16/201719,872
Ahn Chang HoDirector04/10/201777,500
Ahn Chang HoDirector04/10/2017175,375
Suzdak Peter DavidChief Executive Officer03/18/201619,386
Jeong Tae HeumChief Financial Officer01/08/201563,026
Jeong Tae HeumChief Financial Officer01/12/201539,840
Jeong Tae HeumChief Financial Officer01/09/2015150,952
Jeong Tae HeumChief Financial Officer01/08/201570,935
Jeong Tae HeumChief Financial Officer01/12/201545,492
Jeong Tae HeumChief Financial Officer01/09/2015172,708
Ahn Chang HoDirector01/08/201564,000
Ahn Chang HoDirector01/12/201538,755
Ahn Chang HoDirector01/09/2015148,970
Ahn Chang HoDirector01/08/201572,032
Ahn Chang HoDirector01/12/201544,263
Ahn Chang HoDirector01/09/2015170,477
Ahn Chang HoDirector06/12/2014108,954
Ahn Chang HoDirector06/12/2014134,436
McIntosh David MDirector04/14/2014100,000
McIntosh David MDirector04/14/2014100,000
Jeong Tae HeumChief Financial Officer09/09/201336,000
Jeong Tae HeumChief Financial Officer09/09/201336,000
Jeong Tae HeumChief Financial Officer09/09/201332,475
Kivel RichardDirector10/03/20112,600
Brandt Peter C.Director09/09/201197,571
Brandt Peter C.Director09/08/201149,284
Brandt Peter C.Director09/06/201118,923
Brandt Peter C.Director09/07/20115,200
Ahn Chang HoChairman & CEO05/18/20111,320,582
Ahn Chang HoChairman & CEO04/01/2011391,432
Load More Insider Transactions
FUNDS WITH A POSITION IN OCUPHIRE PHARMA INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
GEODE CAPITAL MANAGEMENT, LLC219,1130.00007%No changeOther
BLACKROCK INC.94,3210.00001%1.11%Other
RENAISSANCE TECHNOLOGIES LLC24,2250.00011%NewOther
CHANGE IN SHARES OUTSTANDING FOR OCUPHIRE PHARMA INC
STOCK BUYBACKS FOR OCUPHIRE PHARMA INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
2.69%
1Q
12/31/2023
06/30/2023
9.77%
2Q
12/31/2023
03/31/2023
9.88%
3Q
12/31/2023
12/31/2022
-2.02%
4Q
12/31/2023
09/30/2022
12.24%
5Q
12/31/2023
06/30/2022
17.97%
6Q
12/31/2023
03/31/2022
21.81%
7Q
12/31/2023
12/31/2021
54.91%
8Q
12/31/2023
09/30/2021
35.94%
9Q
12/31/2023
06/30/2021
69.07%
10Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
2.69%
1Q
06/30/2023
9.77%
2Q
03/31/2023
9.88%
3Q
12/31/2022
-2.02%
4Q
09/30/2022
12.24%
5Q
06/30/2022
17.97%
6Q
03/31/2022
21.81%
7Q
12/31/2021
54.91%
8Q
09/30/2021
35.94%
9Q
06/30/2021
69.07%
10Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR OCUPHIRE PHARMA INC
LOADING...